Private Equity

Dealmaking

Managers

Turnaround Deal of the Year: Centre Lane Partners with Capital Brands

Capital Brands had a good product and the right ingredients, it just needed a better blend of marketing and management.

3 min read · 01 April 2021

Managers

Small Market Deal of the Year: Century Park Capital Partners with Mikawaya

Century Park knew that anything as delicious as mochi would eventually become a big hit in the US – it was just a matter of marketing.

3 min read · 01 April 2021

Deals

International Deal of the Year: Ardian with Kersia

In four years, Ardian built up Kersia from being a small business unit into a global leader in biosecurity and food safety.

3 min read · 01 April 2021

Managers

Deal of the Year: Thoma Bravo with Ellie Mae

Thoma Bravo earns our top prize for its sale of Ellie Mae for a cool $11bn after purchasing it for $3.7bn only 18 months earlier.

6 min read · 01 April 2021

Managers

Secondaries Deal of the Year: Clearlake Capital Group with Ivanti

Clearlake Capital Group worked some magic with its single-asset secondaries deal for portfolio company Ivanti.

4 min read · 01 April 2021

Managers

Mid-Market Deal of the Year: Trivest Partners with TurnPoint Services

Plumbing’s not glamorous but it’s an essential market, and Trivest swooped in and expanded TurnPoint Services to meet demand.

4 min read · 01 April 2021

Deals

WCAS-backed SpringStone seeks $1bn-plus in sale

The timing of a prospective sale comes as more individuals continue seeking mental health services coming out of the pandemic, driving a massive need for more psychiatric hospitals.

3 min read · 31 March 2021

Deals

Partners Group to make 5x on sale of GlobalLogic

With the sale the sale of GlobalLogic, Partners Group is poised to receive net proceeds of $3.8bn, sources familiar with the situation told PE Hub.

1 min read · 31 March 2021

THL investment values Bazaarvoice at $1.5b-plus, Ares gains secondaries business through $1b Landmark acquisition, Avista sees opportunity to simplify early-stage drug-development

THL's investment in Bazaarvoice puts company at an over $1.5 billion valuation and Ares agrees to buy secondaries shop Landmark Partners.

2 min read · 31 March 2021

Deals

Avista backs eMolecules as pharma seeks to simplify supply chain

Accounting for eMolecules and its pending investment in French drugmaker Cooper, Avista Fund V is 50% deployed.

3 min read · 31 March 2021

Showing 7,331 to 7,340 of 42,641 results
1…733735…1000